P91.2
Neonatal cerebral leukomalacia
Clinical Classification Guidelines
Inclusion Terms
- Periventricular leukomalacia
Medical Intelligence & Overview
Neonatal cerebral leukomalacia, commonly known as periventricular leukomalacia (PVL), is a type of brain injury that occurs in newborns, especially premature infants. It involves the death or damage of white matter in the brain around the ventricles, which are fluid-filled spaces. This condition can impact a child's neurological development and may lead to motor, cognitive, or visual impairments as they grow.
Causes & Symptoms
Clinical Causes: Premature birth: The most significant risk factor, as the brain's white matter is particularly vulnerable in premature infants. Lack of oxygen (hypoxia): Instances where the baby's brain doesn't receive enough oxygen, causing damage. Infections: Maternal or fetal infections that cause inflammation in the brain tissue. Blood flow issues: Abnormal blood flow or bleeding within the brain's small vessels can damage white matter. Prenatal stress or injury: Maternal health issues, such as hypertension or preeclampsia, can contribute to PVL. Respiratory distress: Complications affecting breathing and oxygen supply during or after delivery.
Key Symptoms: Poor muscle tone (hypotonia) Delayed motor skills development, such as difficulty sitting, crawling, or walking Spasticity or abnormal muscle stiffness Coordination and balance difficulties Visual impairments, including strabismus or vision loss Potential cognitive delays and learning difficulties
Diagnostic & Treatment
Diagnosis Path: Diagnosis of periventricular leukomalacia primarily involves neuroimaging studies. These include:
Treatment Protocols: There is no specific cure for PVL, but management strategies aim to reduce complications and support development:
Clinical Advice & FAQs
Billing Guidance
Is P91.2 a billable ICD-10 code?
Yes, P91.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P91.2?
Clinical documentation must specify the nature of Neonatal cerebral leukomalacia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference